Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3

BACKGROUND: Galectin-3 (Gal-3) is a promising target in cancer therapy with a high therapeutic potential due to its abundant localization within the tumor tissue and its involvement in tumor development and proliferation. Potential clinical application of Gal-3-targeted inhibitors is often complicat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nanobiotechnology
Main Authors: Bojarová, P., Tavares, M. R., Laaf, D., Bumba, L., Petrásková, L., Konefał, R., Bláhová, M., Pelantová, H., Elling, L., Etrych, T., Chytil, P., Křen, V.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6146777/
https://ncbi.nlm.nih.gov/pubmed/30236114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-018-0399-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados